Baxion
Screening
Tags
Alerts
Theme
Dermata Therapeutics, Inc.
DRMA
·
NASDAQ
·
$1.23
Share Price as of 11/2
·
$838,315
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/11/26
10-Q
Q1 ended 03/31/26
05/13/26
10-K
FY 2025
03/26/26
10-Q
Q3 ended 09/30/25
11/14/25
10-Q
Q2 ended 06/30/25
08/13/25
Disclosures
Filter
8-K
Current report
10/29/26
8-K
Current report
08/17/26
8-K
Current report
08/11/26
8-K
Current report
08/05/26
8-K
Current report
05/27/26
Prospectuses and Registrations
Filter
424B3
Prospectus
10/21/26
S-3
Shelf registration
10/09/26
S-8
Registration of securities for employees
06/04/26
424B3
Prospectus
05/29/26
S-3/A
Shelf registration (amended)
05/22/26
Proxies
Filter
DEF 14A
Definitive proxy
04/17/26
DEFA14A
Additional proxy materials
04/17/26
PRE 14A
Preliminary proxy
04/07/26
DEF 14A
Definitive proxy
06/02/25
DEFA14A
Additional proxy materials
06/02/25
Ownership
Filter
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
06/16/26
SC 13D
Beneficial ownership
06/01/26
SC 13G/A
Beneficial ownership (amended)
05/13/26
Other
Filter
EFFECT
Request for effectiveness
10/20/26
25-NSE
Removal from listing
08/17/26
EFFECT
Request for effectiveness
05/29/26
CORRESP
Correspondence with the SEC
05/27/26
ARS
Annual report to shareholders
04/17/26
Latest Filings
Filter
8-K
Current report
10/29/26
424B3
Prospectus
10/21/26
EFFECT
Request for effectiveness
10/20/26
S-3
Shelf registration
10/09/26
8-K
Current report
08/17/26
Ownership
Filter
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
06/16/26
SC 13D
Beneficial ownership
06/01/26
SC 13G/A
Beneficial ownership (amended)
05/13/26